| |
 |
|
|
|
|
|
Poster: 278
Visits: 113
Title: MYC and CHK1 Dependent Cell Death in T-cell Lymphoma and Hodgkin Lymphoma Cells and Human Xenograft Models With Anti-Proteasomal Therapy
Authors: Andrew Evens ,
Centre: Tufts Medical Center
|
|
You must be registered to reply or comment.
|
|
MYC AND CHK1 DEPENDENT CELL DEATH IN T-CELL LYMPHOMA AND HODGKIN LYMPHOMA CELLS AND HUMAN XENOGRAFT MODELS WITH ANTI-PROTEASOMAL THERAPY
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 10
Visits: 365
Title: Efficacy and Safety of Lenalidomide and Rituximab vs Placebo and Rituximab in a Phase 3 Trial in Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: John Leonard , Marek Trne&711;n, Phillip Scheinberg, Kensei Tobinai, Nathan H. Fowler, Nurgul Kilavuz, Pierre Fustier, Barbara Amoroso, and John G. Gribben
Centre: Weill Cornell Medical College,
|
|
|
|
